Trial · NCT03204786
Registered outcomes48
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
21 to 40 of 48
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Secondary | Change From Baseline on Urine Clinical Labs (Osmolality) During Treatment. | baseline to 4-week, 8-week, and 12-week | |
| Secondary | Change From Baseline on Vital Signs (Systolic Blood Pressure) During Treatment. | Up to 12 weeks | |
| Secondary | Change From Baseline on Vital Signs (Diastolic Blood Pressure) During Treatment. | Up to 12 weeks | |
| Secondary | Change From Baseline on Vital Signs (Pulse) During Treatment. | Up to 12 weeks | |
| Secondary | Change From Baseline on Height During Treatment. | baseline to 4-week, 8-week, and 12-week | |
| Secondary | Change From Baseline on Weight During Treatment. | baseline to 4-week, 8-week, and 12-week | |
| Secondary | Change From Baseline on the Dosage Record Treatment Emergent Symptom Scale (DOTES) During Treatment. | Up to 12 weeks | The DOTES evaluates a subset of symptoms related to various medical conditions. The clinician assesses intensity (0=Not assessed, 1=Not present, 2=Mild, 3=Moderate, 4=Severe), relatedness (0=None, 1=Remote, 2=Possible, 3=Probable, 4=Defined), and action taken (0=None, 1=Increased , 2=Contractive Rx, 3=Change Dose, 4=Change Dose Plus Contractive Rx, 5=Suspend Rx, 6=Discontinue Rx). Side effects are included that have increased in severity, become more likely to be related, or require action. Change from baseline is reported as the number of participants with change in these side effects during treatment. |
| Secondary | Number of Participants Reporting Aggression Using the Overt Aggression Scale (OAS) During Treatment. | baseline, 4-weeks, 8-weeks | The scale evaluates the child participant's aggression. The number of children who exhibited aggression as reported by the parent is reported. |
| Secondary | Adverse Event Severity | Up to 12 weeks | Adverse events collated according to intensity for each pre-allocated treatment group. |
| Other | Baseline Vasopressin Concentration Predicting Primary and Secondary Behavioral Outcome Measures. | 4-week; 8-week | |
| Other | Change From Baseline in Vineland Adaptive Behavior Scales, Third Edition (VABS-3) - Social Skills and Relationships Domain During Treatment. | 4-week; 8-week | |
| Other | Change From Baseline in Parent Rated Pediatric Quality of Life (PedsQL) Inventory Scores During Treatment. | 4-week; 8-week | |
| Other | Change From Baseline on Eye Gaze Assessment (Eye Tracking) During Treatment. | 4-week; 8-week | |
| Other | Change From Baseline on the Developmental Neuropsychological Assessment, Second Edition (NEPSY-II) Theory of Mind Test During Treatment. | 4-week; 8-week | |
| Other | Change From Baseline the Diagnostic Analysis of Nonverbal Accuracy, Second Edition (DANVA-2) Child Voices Prosody Test During Treatment. | 4-week; 8-week | |
| Other | Change From Baseline in Parent Rated Stanford Social Motivation Scale (Also Known as the Stanford Social Dimensional Scale) Total Scores During Treatment. | 4-week; 8-week | |
| Other | Change From Baseline in Parent Rated Anxiety Scale - Autism Spectrum Disorder (PRAS-ASD) Score During Treatment. | 4-week; 8-week | |
| Other | Change From Baseline in Parent Rated Social Responsiveness Scale, Second Edition (SRS-2) Social Avoidance Factor Score During Treatment. | 4-week; 8-week | |
| Other | Change From Baseline in Parent Rated Social Responsiveness Scale, Second Edition (SRS-2) Emotion Recognition Factor Score During Treatment. | 4-week; 8-week | |
| Other | Change From Baseline in Parent Rated Social Responsiveness Scale, Second Edition (SRS-2) Interpersonal Relatedness Factor Score During Treatment. | 4-week; 8-week |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03204786/registered?page=2